Mitsubishi UFJ Trust & Banking
HZNP

Mitsubishi UFJ Trust & Banking’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-155,428
Closed -$18M – 1174
2023
Q3 		$18M Sell
155,428
-1,825
-1% -$196K 0.05% 400
2023
Q2 		$16.2M Buy
157,253
+1,173
+0.8% +$124K 0.04% 449
2023
Q1 		$17M Sell
156,080
-121
-0.1% -$13.4K 0.04% 430
2022
Q4 		$17.8M Buy
156,201
+15,529
+11% +$1.29M 0.05% 408
2022
Q3 		$8.71M Sell
140,672
-20,277
-13% -$1.42M 0.02% 550
2022
Q2 		$12.8M Buy
160,949
+20,418
+15% +$1.93M 0.03% 480
2022
Q1 		$14.8M Sell
140,531
-3,712
-3% -$362K 0.03% 474
2021
Q4 		$15.5M Sell
144,243
-507
-0.4% -$55.3K 0.03% 493
2021
Q3 		$15.9M Sell
144,750
-1,004
-0.7% -$104K 0.03% 478
2021
Q2 		$13.6M Buy
145,754
+15,978
+12% +$1.47M 0.03% 531
2021
Q1 		$11.9M Sell
129,776
-27,920
-18% -$2.36M 0.03% 550
2020
Q4 		$11.5M Buy
+157,696
New +$11.7M 0.02% 591

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's HZNP Position: Q4 2023 in Review

Mitsubishi UFJ Trust & Banking sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 155,428 shares — an estimated $18M sold.

Mitsubishi UFJ Trust & Banking first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $18M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Mitsubishi UFJ Trust & Banking reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 155,428 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $18M.
  • Mitsubishi UFJ Trust & Banking first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Mitsubishi UFJ Trust & Banking's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $18M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q4 2023, filed 9 Feb 2024.